Gp. Linette et al., CROSS-TALK BETWEEN CELL-DEATH AND CELL-CYCLE PROGRESSION - BCL-2 REGULATES NFAT-MEDIATED ACTIVATION, Proceedings of the National Academy of Sciences of the United Statesof America, 93(18), 1996, pp. 9545-9552
BCL-2-deficient T cells demonstrate accelerated cell cycle progression
and increased apoptosis following activation. Increasing the levels o
f BCL-2 retarded the G(0) --> S transition, sustained the levels of cy
clin-dependent kinase inhibitor p27(Kip1), and repressed postactivatio
n death. Proximal signal transduction events and immediate early gene
transcription were unaffected. However, the transcription and synthesi
s of interleukin 2 and other delayed early cytokines were markedly att
enuated by BCL-2. In contrast, a cysteine protease inhibitor that also
blocks apoptosis had no substantial affect upon cytokine production.
Interleukin 2 expression requires several transcription factors of whi
ch nuclear translocation of NFAT (nuclear factor of activated T cells)
and NFAT-mediated transactivation were impaired by BCL-2. Thus, selec
t genetic aberrations in the apoptotic pathway reveal a cell autonomou
s coregulation of activation.